Information Provided By:
Fly News Breaks for November 6, 2018
ATRS
Nov 6, 2018 | 14:03 EDT
Jefferies analyst Anthony Petrone raised his price target on Antares Pharma shares to $8 from $7 following the company's Q3 report and operating update. Petrone keeps a Buy rating on Antares shares, which are up 3c, or 1%, to $3.53 in afternoon trading.
News For ATRS From the Last 2 Days
There are no results for your query ATRS